BRIEF-Praxis Precision Medicines Terminates 2024 Sales Agreement With Jefferies - SEC Filing

Reuters
Sep 06
BRIEF-<a href="https://laohu8.com/S/PRAX">Praxis Precision Medicines</a> Terminates 2024 Sales Agreement With Jefferies - SEC Filing

Sept 5 (Reuters) - Praxis Precision Medicines Inc PRAX.O:

  • PRAXIS PRECISION MEDICINES INC - TERMINATES 2024 SALES AGREEMENT WITH JEFFERIES - SEC FILING

  • PRAXIS PRECISION MEDICINES INC - ENTERS 2025 SALES AGREEMENT WITH TD SECURITIES - SEC FILING

Source text: [ID:n0001104659-25-087865]

Further company coverage: PRAX.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10